Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026)
Bio-Rad Laboratories' (BIO) quarterly Return on Capital Employed came in at 0.62% in Q1 2026, down 499.0% year-on-year from 0.16% in Q1 2025, and up 26.69% on a QoQ basis from 0.49% in Q4 2025.
Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 17 years of Return on Capital Employed data on file, last reported at 0.62% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 499.0% year-over-year to 0.62% in Q1 2026; TTM through Mar 2026 was 0.62%, a 499.0% decrease from a year earlier, with the FY2025 full-year figure at 0.5%, down 553.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 0.62%, up from 0.49% in the prior quarter.
- Over the last five years, Return on Capital Employed for BIO reached as high as 1221.09% in Q1 2024 and fell as low as 73.98% in Q2 2025.
- Historically, Return on Capital Employed has averaged 80.6% across 5 years, with a median of 5.18% in 2025.
- Across the five-year window, Return on Capital Employed soared 121471 bps in 2024 and slumped 121547 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 8.84% in 2022, then plunged by 33 bps to 5.96% in 2023, then climbed by 3 bps to 6.16% in 2024, then slumped by 92 bps to 0.49% in 2025, then grew by 27 bps to 0.62% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 0.62% in Q1 2026, 0.49% in Q4 2025, and 5.18% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 9.30% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 24.24% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 8.38% |
| 10 | Bio-Rad Laboratories | 8.60 Bn | 7.04 Bn | 309.40 Mn | 0.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62% |
| Dec 31, 2025 | 0.49% |
| Sep 30, 2025 | 5.18% |
| Jun 30, 2025 | -73.98% |
| Mar 31, 2025 | 5.62% |
| Dec 31, 2024 | 6.16% |
| Mar 31, 2024 | 1,221.09% |
| Dec 31, 2023 | 5.96% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | 2.98% |
| Mar 31, 2023 | 6.38% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | 4.21% |
| Mar 31, 2022 | 8.22% |
| Dec 31, 2021 | 5.32% |
| Sep 30, 2021 | 3.36% |
| Jun 30, 2021 | 3.74% |
| Mar 31, 2021 | 6.92% |
| Dec 31, 2020 | 7.68% |